PhoenixBio Co., Ltd. (TYO:6190)
344.00
+1.00 (0.29%)
Aug 6, 2026, 2:18 PM JST
PhoenixBio Employees
PhoenixBio had 55 employees as of March 31, 2026. The number of employees decreased by 14 or -20.29% compared to the previous year.
Employees
55
Change (1Y)
-14
Growth (1Y)
-20.29%
Revenue / Employee
28.45M JPY
Profits / Employee
2.27M JPY
Market Cap
1.40B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 55 | -14 | -20.29% |
| Mar 31, 2025 | 69 | -1 | -1.43% |
| Mar 31, 2024 | 70 | 5 | 7.69% |
| Mar 31, 2023 | 65 | -1 | -1.52% |
| Mar 31, 2022 | 66 | -3 | -4.35% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Transgenic Group | 227 |
| Kohjin Bio | 176 |
| Human Metabolome Technologies | 62 |
| Ribomic | 25 |
| Cyfuse Biomedical K.K. | 23 |
| D. Western Therapeutics Institute | 19 |
| TMS Co., Ltd. | 18 |
| Kringle Pharma | 17 |